Back
Monopar Therapeutics Stock Price Chart
The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.
Buy
53
MNPR
Monopar Therapeutics
Last Price:
$37.90
Seasonality Move:
-21.29%
7 Day Trial
ALL ACCESS PASS
$
7
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.12 | Buy |
| 20-day SMA: | 35.67 | Sell |
| 50-day SMA: | 37.27 | Sell |
| 200-day SMA: | 25.06 | Buy |
| 8-day EMA: | 33.52 | Buy |
| 20-day EMA: | 35.25 | Buy |
| 50-day EMA: | 36.33 | Sell |
| 200-day EMA: | 27.5 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.62 | Sell |
| Relative Strength Index (14 RSI): | 49.43 | Sell |
| Chaikin Money Flow: | 19753 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.11 - 40.93) | Sell |
| Bollinger Bands (100): | (30.98 - 43.28) | Sell |
Monopar Therapeutics Technical Analysis
| May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 35.59 while MNPR 8-day simple moving average is 33.12, which is a Buy signal.
-
The stock price of MNPR is 35.59 while Monopar Therapeutics 20-day SMA is 35.67, which makes it a Sell.
-
Monopar Therapeutics 50-day simple moving average is 37.27 while MNPR share price is 35.59, making it a Sell technically.
-
MNPR stock price is 35.59 and Monopar Therapeutics 200-day simple moving average is 25.06, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
53
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a BuyThe current Monopar Therapeutics [MNPR] share price is $35.59. The Score for MNPR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
217.6M
Price in USD:
35.59
Share Volume:
35.5K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Buy
53
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 35.59 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 35.59 while MNPR 8-day exponential moving average is 33.52, which is a Buy signal.
-
The stock price of MNPR is 35.59 while Monopar Therapeutics 20-day EMA is 35.25, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 36.33 while MNPR share price is 35.59, making it a Sell technically.
-
MNPR stock price is 35.59 and Monopar Therapeutics 200-day simple moving average is 27.50, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.77 per share, and an increase next year of $0.41 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is -1.62, suggesting Monopar Therapeutics is a Sell
-
Monopar Therapeutics Relative Strength Index (RSI) is 49.43, which suggest Monopar Therapeutics is oversold
-
The Bollinger Bands (25) for Monopar Therapeutics is (33.11 - 40.93), which suggest Monopar Therapeutics is a Sell
-
The Bollinger Bands (100) for Monopar Therapeutics is (30.98 - 43.28), which suggest Monopar Therapeutics is a Sell
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.